Your browser is no longer supported. Please, upgrade your browser.
PLx Pharma Inc.
Index- P/E- EPS (ttm)-2.66 Insider Own1.80% Shs Outstand23.64M Perf Week-3.23%
Market Cap366.38M Forward P/E- EPS next Y-1.47 Insider Trans1.66% Shs Float22.14M Perf Month-31.13%
Income-42.70M PEG- EPS next Q-0.46 Inst Own41.50% Short Float8.94% Perf Quarter-30.85%
Sales0.00M P/S- EPS this Y54.60% Inst Trans1.52% Short Ratio4.47 Perf Half Y18.47%
Book/sh1.70 P/B7.92 EPS next Y30.40% ROA-79.90% Target Price24.00 Perf Year305.72%
Cash/sh2.95 P/C4.57 EPS next 5Y40.00% ROE-315.50% 52W Range3.00 - 21.50 Perf YTD144.02%
Dividend- P/FCF- EPS past 5Y35.70% ROI- 52W High-37.86% Beta4.52
Dividend %- Quick Ratio26.30 Sales past 5Y- Gross Margin- 52W Low345.33% ATR1.26
Employees8 Current Ratio26.80 Sales Q/Q- Oper. Margin- RSI (14)32.65 Volatility8.88% 8.29%
OptionableYes Debt/Eq0.00 EPS Q/Q-20.60% Profit Margin- Rel Volume0.30 Prev Close13.47
ShortableYes LT Debt/Eq0.00 EarningsAug 06 BMO Payout- Avg Volume443.32K Price13.36
Recom2.00 SMA20-21.11% SMA50-23.15% SMA2004.92% Volume84,633 Change-0.82%
Sep-21-21Initiated BWS Financial Buy $29
Apr-09-21Initiated Oppenheimer Outperform $20
May-18-20Resumed JMP Securities Mkt Outperform $15 → $10
Apr-12-19Resumed Janney Buy
Jan-14-19Downgrade Raymond James Outperform → Mkt Perform
Oct-21-21 12:18PM  
Oct-14-21 02:09PM  
Sep-24-21 08:11PM  
Sep-17-21 11:42AM  
Sep-09-21 06:50AM  
Aug-26-21 06:00AM  
Aug-06-21 06:50AM  
Aug-02-21 04:30PM  
Jul-26-21 04:30PM  
Jul-22-21 04:30PM  
Jul-20-21 04:20PM  
Jul-19-21 05:00PM  
Jul-13-21 05:00PM  
Jul-12-21 04:30PM  
Jul-06-21 11:49AM  
Jun-09-21 04:30PM  
May-18-21 07:04AM  
May-14-21 06:50AM  
May-11-21 08:33AM  
May-03-21 04:30PM  
Apr-22-21 08:11AM  
Mar-12-21 06:50AM  
Mar-11-21 05:00PM  
Mar-05-21 02:34AM  
Mar-04-21 05:30PM  
Mar-03-21 08:48AM  
Mar-02-21 04:05PM  
Mar-01-21 11:47AM  
Nov-27-20 01:23PM  
Nov-16-20 04:05PM  
Nov-12-20 05:30PM  
Nov-03-20 06:50AM  
Sep-14-20 04:30PM  
Sep-03-20 11:34AM  
Aug-24-20 11:33AM  
Aug-14-20 08:26AM  
Aug-05-20 04:30PM  
Jun-04-20 09:33PM  
Jun-02-20 11:26AM  
May-18-20 04:30PM  
May-15-20 06:50AM  
May-04-20 06:50AM  
Mar-13-20 08:50AM  
Mar-03-20 06:50AM  
Feb-21-20 06:50AM  
Jan-30-20 07:30AM  
Jan-23-20 10:21AM  
Jan-07-20 06:50AM  
Jan-06-20 06:50AM  
Nov-30-19 11:39AM  
Nov-26-19 03:33AM  
Nov-19-19 10:33AM  
Nov-08-19 06:50AM  
Oct-28-19 06:50AM  
Sep-13-19 09:44PM  
Sep-10-19 12:03PM  
Sep-03-19 06:50AM  
Aug-28-19 04:30PM  
Aug-09-19 06:50AM  
Aug-02-19 10:30AM  
Jul-30-19 04:30PM  
Jul-10-19 07:16AM  
Jun-19-19 07:00AM  
Jun-11-19 12:50PM  
Jun-10-19 04:30PM  
May-21-19 11:34AM  
May-10-19 06:50AM  
May-03-19 10:30AM  
May-02-19 06:50AM  
Mar-26-19 06:30PM  
Mar-08-19 06:50AM  
Feb-25-19 04:30PM  
Feb-20-19 04:55PM  
Feb-14-19 11:30AM  
Jan-17-19 09:55AM  
Dec-20-18 07:32PM  
Dec-18-18 04:30PM  
Nov-19-18 09:31AM  
Nov-09-18 06:50AM  
Nov-01-18 07:00AM  
Oct-01-18 08:57AM  
Sep-10-18 04:30PM  
Aug-10-18 07:00AM  
Jun-11-18 04:30PM  
May-11-18 06:50AM  
Apr-24-18 07:50AM  
Mar-23-18 06:50AM  
Mar-15-18 04:30PM  
Nov-21-17 07:29PM  
Nov-10-17 06:00AM  
PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and ulcers as compared with immediate-release aspirin, after seven days of treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard drug delivery system, such as PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, which are in Phase I clinical stage for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Valentino Michael JExecutive ChairmanJun 14Buy12.488,00099,870494,690Jun 15 04:47 PM
Valentino Michael JExecutive ChairmanMar 05Buy8.0025,000200,000486,690Mar 09 05:06 PM
HADDEN JOHNDirectorDec 14Buy5.451,0005,4483,690Dec 15 05:38 PM
HADDEN JOHNDirectorNov 25Buy5.485002,7382,690Nov 25 04:08 PM
Valentino Michael JExecutive ChairmanNov 18Buy3.79264,9001,003,176461,690Nov 20 07:46 PM